Trial Profile
A Prospective Study for the Effects of Chronic Use of Doxazosin on Alpha 1-Adrenergic Receptors in Men With Benign Prostatic Hyperplasia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Doxazosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Pharmacodynamics
- 25 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Aug 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 04 Sep 2008 New trial record.